Medpace Holdings Inc (NASDAQ:MEDP) currently has a daily average trading volume of 466.27K but it saw 1419450 shares traded in last market. With a market cap of 8.53B USD, the company’s current market price of $290.54 came rising about 2.93 while comparing to the previous closing price of $282.28. In past 52 weeks, the stock remained buoying in the range of price level as high as $459.77 and as low as $250.05. In the recent trading on the day, stock has struck highest price mark of $282.84 while lowest mark touched by it was $297.34.
Taking a look at 20-day trading activity of Medpace Holdings Inc (MEDP) gives us an average price of $298.32, while its current price level is -36.81% below from 52-week high level whereas it is 16.19% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $317.97 while that of 200 days or SMA-200 reads an average of $346.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.09% during that period while stretching the period over a month that decreases to 5.64%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 43.78 which implies that the stock is in neutral territory.
TD Cowen downgraded its recommendation for the stock as a “Hold” from “Buy” on April 14, 2025 while assigning a price target of $328. Leerink Partners issued its recommendations for the stock as it initiated the price target for the stock is $330.
Over the week, MEDP’s stock price is moving -4.74% down while it is -12.11% when we observe its performance for the past one month. Year-to-date it is -12.55% down and over the past year, the stock is showing a downside performance of -21.90%.
The company is expected to be releasing its next quarterly report on 2025-Apr-20, for which analysts forecasted an EPS of 3.01 while estimate for next year EPS is 13.1. In next quarter, company is expected to be making quarterly sales of $542.78M as analysts are expecting the sales for current fiscal year at $2.18B and seeing the company making $2.28B in sales next year. Moreover, analysts are in estimates of $537.7M for current-quarter revenue.
Currently, Medpace Holdings Inc’s total number of outstanding shares is 29.77M with 19.78% of that held by the insiders while 88.53% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 56.14% and return on equity (ROE) at 65.82%. It has a price to earnings ratio (P/E ratio) of 23.00 while having a 22.05 of forward P/E ratio. Stock’s beta reads 1.55. Stock has a price to book (P/B) ratio of 14.57 while price to sale or P/S ratio amounts to 4.05. Its return on asset (ROA) is 22.55% on average.
